How can rehospitalisations of patients with schizophrenia be avoided? A comparison between different compliance programs

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN19638644

Enrollment

896

Registered

2007-02-14

Start date

2006-09-01

Completion date

Unknown

Last updated

2019-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia or schizoaffective disorder Mental and Behavioural Disorders Schizophrenia, schizotypal and delusional disorders

Interventions

1. Psychoeducation by professionals 2. Psychoeducation by peer-moderators 3. Video-education

Eligibility

Inclusion criteria

Inclusion criteria: 1. Schizophrenia or schizoaffective disorder (International Classification of Diseases [ICD-10]) 2. Age 18 to 67 years 3. Hospitalised or treated in a day care clinic

Exclusion criteria

Exclusion criteria: 1. More than 12 months of hospitalisation within the last two years 2. Substance-dependency (principal diagnosis) 3. Mental retardation ICD-10 Chapter F70-79 4. Fluency of German language not given

Design outcomes

Primary

Measure	Time frame
Rehospitalisation rate	—

Secondary

Measure	Time frame
1. Rehospitalisation days 2. Resulting costs per patient 3. Cost-benefit-analysis of the different interventions 4. Compliance 5. Compliance self-assesment (Medication Adherence Rating Scale [MARS]/Drug Attitude Inventory [DAI]) 6. Knowledge of illness 7. Attitude towards illness 8. Quality of life (World Health Organisation Quality Of Life [WHOQOL]-BREF) 9. Satisfaction questionnaire (ZUF-8) 10. Duration of consultation time 11. Dealing with mental illness (Mantonakis, Family Member Questionnaire [FMQ], Beck Depression Inventory [BDI])	—

Measure

Time frame

1. Rehospitalisation days 2. Resulting costs per patient 3. Cost-benefit-analysis of the different interventions 4. Compliance 5. Compliance self-assesment (Medication Adherence Rating Scale [MARS]/Drug Attitude Inventory [DAI]) 6. Knowledge of illness 7. Attitude towards illness 8. Quality of life (World Health Organisation Quality Of Life [WHOQOL]-BREF) 9. Satisfaction questionnaire (ZUF-8) 10. Duration of consultation time 11. Dealing with mental illness (Mantonakis, Family Member Questionnaire [FMQ], Beck Depression Inventory [BDI])

—

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026